🔴 Connect Biopharma is trading 5.24% down today after broader biotech weakness

Connect Biopharma is trading 5.24% down at $2.33 after broader biotech weakness and profit-taking pressured the sector on August 20, 2026.

• Biotech ETF XBI is down 2.47%, while major U.S. indexes are also lower, reinforcing risk-off sentiment.
• No new company-specific announcement was identified on August 20.
• The latest investor update, the August 12 second-quarter report, highlighted completed Phase 2 enrollment; topline results are expected in September 2026.